Abstract
Endometrial cancer is one of the most common gynecological malignancy worldwide. Though there are a large number of completed prospective and retrospective studies, adjuvant treatment remains poorly defined, mainly due to the heterogeneity in selection criteria, different treatment approaches and low recurrence rates in good risk early stage disease. This article comprehensively covers the different risk stratification approaches and the current concepts and evidences in tailoring of adjuvant treatment in carcinoma of the endometrium. Keywords: Endometrial cancer, malignancy, endometrium treatment Cite this Article Kunheri B, Vijayakumar DK,Anand RK. Adjuvant Treatment in Carcinoma of Endometrium: Where Do We Stand? Research & Reviews: Journal of Oncology and Hematology. 2016; 5(3): 22–29p.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
